Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Focused ultrasound for epilepsy that does not respond to medicines

Tests low-intensity focused ultrasound in adults with hard-to-treat epilepsy who have implanted electrodes.

Plain-language title generated from the registry record
Registry title: Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy

Key facts

Where
Roanoke, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT07353918, who can take part

Where in United States

  • Fralin Biomedical Research Institute at VTCRoanoke, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Carilion Clinic
Trial code
NCT07353918
Record updated
21 January 2026
Original description
This study is an invite only study looking at the effects of Low-Intensity Focused Ultrasound (LIFU) on epilepsy patients with implanted electrodes under the care of Dr. Shah.Read full original descriptionShow less

Neuromodulation Using Low-intensity Focused Ultrasound for Potential Treatment for Medically Refractory Temporal Lobe Epilepsy

This study is an invite only study looking at the effects of Low-Intensity Focused Ultrasound (LIFU) on epilepsy patients with implanted electrodes under the care of Dr. Shah.

Inclusion: Diagnosis of medically refractory focal epilepsy of mesial temporal onset; RNS system implantation in the hippocampus; Prior MRI and CT of the head; Able to consent for themselves; Internet access.

Exclusion: TBI (ongoing, or in the prior 6 months); Progressive diseases - such as autoimmune epilepsies or diagnosis of a progressive neurological disorder; History of suicidal ideation or attempts in the last 6 months; Currently pregnant or breastfeeding; Status epilepticus within one year of study start.

ClinicalTrials.gov NCT07353918